-
Antibody evasion associated with the RBD significant mutations in several emerging SARS-CoV-2 variants and its subvariants Drug Resist. Updat. (IF 24.3) Pub Date : 2023-09-22 Manojit Bhattacharya, Srijan Chatterjee, Sang-Soo Lee, Kuldeep Dhama, Chiranjib Chakraborty
Since the origin of the wild strain of SARS-CoV-2, several variants have emerged, which were designated as VOC, VOI, and VUM from time to time. The Omicron variant is noted as the recent VOC. After the origin of the Omicron variant on November 2021, several subvariants of Omicron have originated subsequently, like BA.1/2, BA.2.75/2.75.2, BA.4/5, BF.7, BQ.1/1.1, XBB.1/1.5, etc. which are circulated
-
Genetics and Pathogenesis of Dystonia Ann. Review Paleopathol. Mech. Disease (IF 36.2) Pub Date : 2023-09-22 Mirja Thomsen, Lara M. Lange, Michael Zech, Katja Lohmann
Dystonia is a clinically and genetically highly heterogeneous neurological disorder characterized by abnormal movements and postures caused by involuntary sustained or intermittent muscle contractions. A number of groundbreaking genetic and molecular insights have recently been gained. While they enable genetic testing and counseling, their translation into new therapies is still limited. However,
-
Antibody and B Cell Responses to SARS-CoV-2 Infection and Vaccination: The End of the Beginning Ann. Review Paleopathol. Mech. Disease (IF 36.2) Pub Date : 2023-09-22 Katharina Röltgen, Scott D. Boyd
As the COVID-19 pandemic has evolved during the past years, interactions between human immune systems, rapidly mutating and selected SARS-CoV-2 viral variants, and effective vaccines have complicated the landscape of individual immunological histories. Here, we review some key findings for antibody and B cell–mediated immunity, including responses to the highly mutated omicron variants; immunological
-
PRMT inhibitor promotes SMN2 exon 7 inclusion and synergizes with nusinersen to rescue SMA mice EMBO Mol. Med. (IF 11.1) Pub Date : 2023-09-19 Anna J Kordala, Jessica Stoodley, Nina Ahlskog, Muhammad Hanifi, Antonio Garcia Guerra, Amarjit Bhomra, Wooi Fang Lim, Lyndsay M Murray, Kevin Talbot, Suzan M Hammond, Matthew JA Wood, Carlo Rinaldi
Spinal muscular atrophy (SMA) is a leading genetic cause of infant mortality. The advent of approved treatments for this devastating condition has significantly changed SMA patients' life expectancy and quality of life. Nevertheless, these are not without limitations, and research efforts are underway to develop new approaches for improved and long-lasting benefits for patients. Protein arginine methyltransferases
-
Dynamic Multiplex Tissue Imaging in Inflammation Research Ann. Review Paleopathol. Mech. Disease (IF 36.2) Pub Date : 2023-09-19 Stefan Uderhardt, Georgiana Neag, Ronald N. Germain
Inflammation is a highly dynamic process with immune cells that continuously interact with each other and parenchymal components as they migrate through tissue. The dynamic cellular responses and interaction patterns are a function of the complex tissue environment that cannot be fully reconstructed ex vivo, making it necessary to assess cell dynamics and changing spatial patterning in vivo. These
-
Diffuse Pleural Mesothelioma: Advances in Molecular Pathogenesis, Diagnosis and Treatment Ann. Review Paleopathol. Mech. Disease (IF 36.2) Pub Date : 2023-09-19 Christopher A. Febres-Aldana, Rachel Fanaroff, Michael Offin, Marjorie G. Zauderer, Jennifer L. Sauter, Soo-Ryum Yang, Marc Ladanyi
Diffuse pleural mesothelioma (DPM) is a highly aggressive malignant neoplasm arising from the mesothelial cells lining the pleural surfaces. While DPM is a well-recognized disease linked to asbestos exposure, recent advances have expanded our understanding of molecular pathogenesis and transformed our clinical practice. This comprehensive review explores the current concepts and emerging trends in
-
Effective targeting of breast cancer by the inhibition of P-glycoprotein mediated removal of toxic lipid peroxidation byproducts from drug tolerant persister cells Drug Resist. Updat. (IF 24.3) Pub Date : 2023-09-17 Kornélia Szebényi, András Füredi, Eszter Bajtai, Sai Nagender Sama, Agnes Csiszar, Balázs Gombos, Pál Szabó, Michael Grusch, Gergely Szakács
Therapy resistance has long been considered to occur through the selection of pre-existing clones equipped to survive and quickly regrow, or through the acquisition of mutations during chemotherapy. Here we show that following in vitro treatment by chemotherapy, epithelial breast cancer cells adopt a transient drug tolerant phenotype characterized by cell cycle arrest, epithelial-to-mesenchymal transition
-
Rebalancing polyamine levels to treat Snyder–Robinson syndrome EMBO Mol. Med. (IF 11.1) Pub Date : 2023-09-15 Susan K Gilmour
Snyder–Robinson syndrome (SRS) is a rare genetic disorder characterized by intellectual disability and delayed development beginning early in childhood. It was first described in a single family in 1969 as a sex-linked disorder (Snyder & Robinson, 1969) and has since been only identified in less than 100 individuals worldwide. Inherited in an X-linked recessive pattern, SRS has only been identified
-
Difluoromethylornithine rebalances aberrant polyamine ratios in Snyder–Robinson syndrome EMBO Mol. Med. (IF 11.1) Pub Date : 2023-09-13 Tracy Murray Stewart, Jackson R Foley, Cassandra E Holbert, Maxim Khomutov, Noushin Rastkari, Xianzun Tao, Alex R Khomutov, R Grace Zhai, Robert A Casero
Snyder–Robinson syndrome (SRS) results from mutations in spermine synthase (SMS), which converts the polyamine spermidine into spermine. Affecting primarily males, common manifestations of SRS include intellectual disability, osteoporosis, hypotonia, and seizures. Symptom management is the only treatment. Reduced SMS activity causes spermidine accumulation while spermine levels are reduced. The resulting
-
Macrophage colony-stimulating factor as a weapon against cytomegalovirus EMBO Mol. Med. (IF 11.1) Pub Date : 2023-09-12 Eric Solary
Cytomegalovirus (CMV) infection is one of the severe opportunistic infections faced by severely immunocompromised patients. High viral loads cause tissue-invasive disease and expose to death or various indirect effects. Substantial progress was made in monitoring active infection, and antiviral drugs were developed. However, dose-limiting toxicities and genotypic resistance limit therapeutic efficacy
-
Sterile triggers drive joint inflammation in TNF- and IL-1β-dependent mouse arthritis models EMBO Mol. Med. (IF 11.1) Pub Date : 2023-09-11 Alexandra Thiran, Ioanna Petta, Gillian Blancke, Marie Thorp, Guillaume Planckaert, Maude Jans, Vanessa Andries, Korneel Barbry, Elisabeth Gilis, Julie Coudenys, Tino Hochepied, Christian Vanhove, Eric Gracey, Emilie Dumas, Teddy Manuelo, Ivan Josipovic, Geert van Loo, Dirk Elewaut, Lars Vereecke
Arthritis is the most common extra-intestinal complication in inflammatory bowel disease (IBD). Conversely, arthritis patients are at risk for developing IBD and often display subclinical gut inflammation. These observations suggest a shared disease etiology, commonly termed “the gut-joint-axis.” The clinical association between gut and joint inflammation is further supported by the success of common
-
Cingulin regulates hair cell cuticular plate morphology and is required for hearing in human and mouse EMBO Mol. Med. (IF 11.1) Pub Date : 2023-09-11 Guang-Jie Zhu, Yuhang Huang, Linqing Zhang, Keji Yan, Cui Qiu, Yihan He, Qing Liu, Chengwen Zhu, Matías Morín, Miguel Ángel Moreno-Pelayo, Min-Sheng Zhu, Xin Cao, Han Zhou, Xiaoyun Qian, Zhigang Xu, Jie Chen, Xia Gao, Guoqiang Wan
Cingulin (CGN) is a cytoskeleton-associated protein localized at the apical junctions of epithelial cells. CGN interacts with major cytoskeletal filaments and regulates RhoA activity. However, physiological roles of CGN in development and human diseases are currently unknown. Here, we report a multi-generation family presenting with autosomal dominant non-syndromic hearing loss (ADNSHL) that co-segregates
-
Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine EMBO Mol. Med. (IF 11.1) Pub Date : 2023-09-07 Laëtitia Douguet, Ingrid Fert, Jodie Lopez, Benjamin Vesin, Fabien Le Chevalier, Fanny Moncoq, Pierre Authié, Trang-My Nguyen, Amandine Noirat, Fabien Névo, Catherine Blanc, Maryline Bourgine, David Hardy, François Anna, Laleh Majlessi, Pierre Charneau
Human papillomavirus (HPV) infections are the cause of all cervical and numerous oropharyngeal and anogenital cancers. The currently available HPV vaccines, which induce neutralizing antibodies, have no therapeutic effect on established tumors. Here, we developed an immuno-oncotherapy against HPV-induced tumors based on a non-integrative lentiviral vector encoding detoxified forms of the Early E6 and
-
ZAKα/P38 kinase signaling pathway regulates hematopoiesis by activating the NLRP1 inflammasome EMBO Mol. Med. (IF 11.1) Pub Date : 2023-09-07 Lola Rodríguez-Ruiz, Juan M Lozano-Gil, Elena Naranjo-Sánchez, Elena Martínez-Balsalobre, Alicia Martínez-López, Christophe Lachaud, Miguel Blanquer, Toan K Phung, Diana García-Moreno, María L Cayuela, Sylwia D Tyrkalska, Ana B Pérez-Oliva, Victoriano Mulero
Chronic inflammatory diseases are associated with hematopoietic lineage bias, including neutrophilia and anemia. We have recently identified that the canonical inflammasome mediates the cleavage of the master erythroid transcription factor GATA1 in hematopoietic stem and progenitor cells (HSPCs). We report here that genetic inhibition of Nlrp1 resulted in reduced number of neutrophils and increased
-
The definition and global epidemiology of nonmobile colistin resistance (NMCR-3) determinants in Aeromonas from 1968 to 2022 Drug Resist. Updat. (IF 24.3) Pub Date : 2023-09-07 Keyi Yu, Zhenzhou Huang, Yue Xiao, Xuemei Bai, He Gao, Duochun Wang
Polymyxins are the last line of defense in infections caused by multidrug-resistant Gram-negative bacteria. The chromosomal EptA in Aeromonas genus was defined as a nonmobile colistin resistance determinant 3 (NMCR-3). A total of 14 NMCR-3 genotypes were identified. The global prevalence of Aeromonas-borne NMCRs and MCRs indicates an increasing trend from 1968 to 2022. And an index of resistance risk
-
The skin barrier: An extraordinary interface with an exceptional lipid organization Prog. Lipid. Res. (IF 13.6) Pub Date : 2023-09-04 Joke A. Bouwstra, Andreea Nădăban, Wim Bras, Clare McCabe, Annette Bunge, Gerrit S. Gooris
The barrier function of the skin is primarily located in the stratum corneum (SC), the outermost layer of the skin. The SC is composed of dead cells with highly organized lipid lamellae in the intercellular space. As the lipid matrix forms the only continuous pathway, the lipids play an important role in the permeation of compounds through the SC. The main lipid classes are ceramides (CERs), cholesterol
-
CircPTEN suppresses human clear cell renal carcinoma progression and resistance to mTOR inhibitors by targeting epigenetic modification Drug Resist. Updat. (IF 24.3) Pub Date : 2023-09-02 Yangyang Zhan, Yang Liu, Rui Yang, Qiong Chen, Fei Teng, Yueying Huang, Xin Jiang, Yueming Wang, Bin Yu, Ding Zhang, Leilei Bao, Xinli Liu, Jiwei Huang
Renal cell carcinoma (RCC) is known to be the most commonly diagnosed kidney cancer. Clear cell RCC (ccRCC) represents approximately 85% of diagnosed RCC cases. Targeted therapeutics, such as multi-targeted tyrosine kinase inhibitors (TKI) and mTOR inhibitors, are widely used in ccRCC therapy. However, patients treated with mTOR and TKI inhibitors easily acquire drug resistance, making the therapy
-
The fats of the matter: Lipids in prebiotic chemistry and in origin of life studies Prog. Lipid. Res. (IF 13.6) Pub Date : 2023-09-01 Tania C.B. Santos, Anthony H. Futerman
The unique biophysical and biochemical properties of lipids render them crucial in most models of the origin of life (OoL). Many studies have attempted to delineate the prebiotic pathways by which lipids were formed, how micelles and vesicles were generated, and how these micelles and vesicles became selectively permeable towards the chemical precursors required to initiate and support biochemistry
-
Sphingosine 1-phosphate signaling during infection and immunity Prog. Lipid. Res. (IF 13.6) Pub Date : 2023-08-24 Sabira Mohammed, Anu Bindu, Arun Viswanathan, Kuzhuvelil B. Harikumar
Sphingolipids are essential components of all eukaryotic membranes. The bioactive sphingolipid molecule, Sphingosine 1-Phosphate (S1P), regulates various important biological functions. This review aims to provide a comprehensive overview of the role of S1P signaling pathway in various immune cell functions under different pathophysiological conditions including bacterial and viral infections, autoimmune
-
Systemic gene therapy rescues retinal dysfunction and hearing loss in a model of Norrie disease EMBO Mol. Med. (IF 11.1) Pub Date : 2023-08-29 Valda Pauzuolyte, Aara Patel, James R Wawrzynski, Neil J Ingham, Yeh Chwan Leong, Rajvinder Karda, Maria Bitner-Glindzicz, Wolfgang Berger, Simon N Waddington, Karen P Steel, Jane C Sowden
Deafness affects 5% of the world's population, yet there is a lack of treatments to prevent hearing loss due to genetic causes. Norrie disease is a recessive X-linked disorder, caused by NDP gene mutation. It manifests as blindness at birth and progressive sensorineural hearing loss, leading to debilitating dual sensory deprivation. To develop a gene therapy, we used a Norrie disease mouse model (Ndptm1Wbrg)
-
M-CSF directs myeloid and NK cell differentiation to protect from CMV after hematopoietic cell transplantation EMBO Mol. Med. (IF 11.1) Pub Date : 2023-08-28 Prashanth K Kandalla, Julien Subburayalu, Clément Cocita, Bérengère de Laval, Elena Tomasello, Johanna Iacono, Jessica Nitsche, Maria M Canali, Wilfried Cathou, Gilles Bessou, Noushin Mossadegh-Keller, Caroline Huber, Guy Mouchiroud, Roland P Bourette, Marie-France Grasset, Martin Bornhäuser, Sandrine Sarrazin, Marc Dalod, Michael H Sieweke
Therapies reconstituting autologous antiviral immunocompetence may represent an important prophylaxis and treatment for immunosuppressed individuals. Following hematopoietic cell transplantation (HCT), patients are susceptible to Herpesviridae including cytomegalovirus (CMV). We show in a murine model of HCT that macrophage colony-stimulating factor (M-CSF) promoted rapid antiviral activity and protection
-
Metformin rescues migratory deficits of cells derived from patients with periventricular heterotopia EMBO Mol. Med. (IF 11.1) Pub Date : 2023-08-23 Cedric Bressan, Marta Snapyan, Marina Snapyan, Johannes Klaus, Francesco di Matteo, Stephen P Robertson, Barbara Treutlein, Martin Parent, Silvia Cappello, Armen Saghatelyan
Periventricular neuronal heterotopia (PH) is one of the most common forms of cortical malformation in the human cortex. We show that human neuronal progenitor cells (hNPCs) derived from PH patients with a DCHS1 or FAT4 mutation as well as isogenic lines had altered migratory dynamics when grafted in the mouse brain. The affected migration was linked to altered autophagy as observed in vivo with an
-
FADS2 function at the major cancer hotspot 11q13 locus alters fatty acid metabolism in cancer Prog. Lipid. Res. (IF 13.6) Pub Date : 2023-08-18 Kumar S.D. Kothapalli, Hui Gyu Park, Niharika S.L. Kothapalli, J. Thomas Brenna
Dysregulation of fatty acid metabolism and de novo lipogenesis is a key driver of several cancer types through highly unsaturated fatty acid (HUFA) signaling precursors such as arachidonic acid. The human chromosome 11q13 locus has long been established as the most frequently amplified in a variety of human cancers. The fatty acid desaturase genes (FADS1, FADS2 and FADS3) responsible for HUFA biosynthesis
-
-
Treatment Strategies and Drug Resistance Mechanisms in Adenocarcinoma of Different Organs Drug Resist. Updat. (IF 24.3) Pub Date : 2023-08-22 Peng Xing, Shuo Wang, Yu Cao, Bo Liu, Feifei Zheng, Wei Guo, Junhao Huang, Zimo Zhao, Ziyi Yang, Xingda Lin, Liang Sang, Zhe Liu
Adenocarcinoma is a common type of malignant tumor, originating from glandular epithelial cells in various organs, such as pancreas, breast, lung, stomach, colon, rectus, and prostate. For patients who lose the opportunity for radical surgery, medication is available to provide potential clinical benefits. However, drug resistance is a big obstacle to obtain desired clinical prognosis. In this review
-
Triacylglycerol uptake and handling by macrophages: From fatty acids to lipoproteins Prog. Lipid. Res. (IF 13.6) Pub Date : 2023-08-22 Lei Deng, Sander Kersten, Rinke Stienstra
Macrophages are essential innate immune cells and form our first line of immune defense. Also known as professional phagocytes, macrophages interact and take up various particles, including lipids. Defective lipid handling can drive excessive lipid accumulation leading to foam cell formation, a key feature of various cardiometabolic conditions such as atherosclerosis, non-alcoholic fatty liver disease
-
Natural medicinal compounds target signal transduction pathways to overcome ABC drug efflux transporter-mediated multidrug resistance in cancer Drug Resist. Updat. (IF 24.3) Pub Date : 2023-08-21 Pradhapsingh Bharathiraja, Priya Yadav, Andaleeb Sajid, Suresh V. Ambudkar, N. Rajendra Prasad
ATP-binding cassette (ABC) transporters such as ABCB1, ABCG2, and ABCC1 are the major players in drug efflux-mediated multidrug resistance (MDR), which severely affects the efficacy of chemotherapy. Several synthetic compounds block the drug transport by ABC transporters; however, they exhibit a narrow therapeutic window, and produce side effects in non-target normal tissues. Conversely, the downregulation
-
Cell membrane-camouflaged bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer Drug Resist. Updat. (IF 24.3) Pub Date : 2023-08-21 Wei Zhang, Yibao Fan, Jinze Zhang, Dan Shi, Jiahui Yuan, Milad Ashrafizadeh, Wei Li, Man Hu, A.M. Abd El-Aty, Ahmet Hacimuftuoglu, Michael Linnebacher, Yongxian Cheng, Weiguang Li, Shuo Fang, Peng Gong, Xianbin Zhang
Aims Multidrug resistance in pancreatic cancer poses a significant challenge in clinical treatment. Bufalin (BA), a compound found in secretions from the glands of toads, may help overcome this problem. However, severe cardiotoxicity thus far has hindered its clinical application. Hence, the present study aimed to develop a cell membrane-camouflaged and BA-loaded polylactic-co-glycolic acid nanoparticle
-
Functional analysis reveals driver cooperativity and novel mechanisms in endometrial carcinogenesis EMBO Mol. Med. (IF 11.1) Pub Date : 2023-08-17 Matthew Brown, Alicia Leon, Katarzyna Kedzierska, Charlotte Moore, Hayley L Belnoue-Davis, Susanne Flach, John P Lydon, Francesco J DeMayo, Annabelle Lewis, Tjalling Bosse, Ian Tomlinson, David N Church
High-risk endometrial cancer has poor prognosis and is increasing in incidence. However, understanding of the molecular mechanisms which drive this disease is limited. We used genetically engineered mouse models (GEMM) to determine the functional consequences of missense and loss of function mutations in Fbxw7, Pten and Tp53, which collectively occur in nearly 90% of high-risk endometrial cancers.
-
Alteration of tumor suppressors changes the endometrial tumor spectrum EMBO Mol. Med. (IF 11.1) Pub Date : 2023-08-17 Lindsey D Mayo
The most common gynecological cancer in Europe and the United States is endometrial. Like most cancers, early-stage endometrial cancer has a more favorable prognosis, while high-grade, including endometrioid and nonendometrioid, has the worst prognosis. In endometrioid human tumors, the tumor suppressor genes PTEN and p53 (Trp53) are frequently altered or lost, as identified in datasets from The Cancer
-
Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors EMBO Mol. Med. (IF 11.1) Pub Date : 2023-08-17 Sudarshan R Iyer, Kevin Nusser, Kristen Jones, Pushkar Shinde, Clare Keddy, Catherine Z Beach, Erin Aguero, Jeremy Force, Ujwal Shinde, Monika A Davare
ROS1 is the largest receptor tyrosine kinase in the human genome. Rearrangements of the ROS1 gene result in oncogenic ROS1 kinase fusion proteins that are currently the only validated biomarkers for targeted therapy with ROS1 TKIs in patients. While numerous somatic missense mutations in ROS1 exist in the cancer genome, their impact on catalytic activity and pathogenic potential is unknown. We interrogated
-
Involvement of casein kinase 1 epsilon/delta (Csnk1e/d) in the pathogenesis of familial Parkinson's disease caused by CHCHD2 EMBO Mol. Med. (IF 11.1) Pub Date : 2023-08-14 Satoru Torii, Satoko Arakawa, Shigeto Sato, Kei-ichi Ishikawa, Daisuke Taniguchi, Hajime Tajima Sakurai, Shinya Honda, Yuuichi Hiraoka, Masaya Ono, Wado Akamatsu, Nobutaka Hattori, Shigeomi Shimizu
Parkinson's disease (PD) is a common neurodegenerative disorder that results from the loss of dopaminergic neurons. Mutations in coiled-coil-helix-coiled-coil-helix domain containing 2 (CHCHD2) gene cause a familial form of PD with α-Synuclein aggregation, and we here identified the pathogenesis of the T61I mutation, the most common disease-causing mutation of CHCHD2. In Neuro2a cells, CHCHD2 is in
-
H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase Drug Resist. Updat. (IF 24.3) Pub Date : 2023-08-10 Dinoop Ravindran Menon, Heinz Hammerlindl, Gregory Gimenez, Sabrina Hammerlindl, Elmar Zuegner, Joachim Torrano, Natalie Bordag, Abdullah Al Emran, Maybelline Giam, Simon Denil, Norman Pavelka, Aik-Choon Tan, Richard A. Sturm, Nikolas K. Haass, Giulia Rancati, Meenhard Herlyn, Christoph Magnes, Michael R. Eccles, Mayumi Fujita, Helmut Schaider
Aims Drivers of the drug tolerant proliferative persister (DTPP) state have not been well investigated. Histone H3 lysine-4 trimethylation (H3K4me3), an active histone mark, might enable slow cycling drug tolerant persisters (DTP) to regain proliferative capacity. This study aimed to determine H3K4me3 transcriptionally active sites identifying a key regulator of DTPPs. Methods Deploying a model of
-
Structure, function, and inhibition of catalytically asymmetric ABC transporters: Lessons from the PDR subfamily Drug Resist. Updat. (IF 24.3) Pub Date : 2023-08-05 Atanu Banerjee, Jorgaq Pata, Vincent Chaptal, Ahcène Boumendjel, Pierre Falson, Rajendra Prasad
ATP-binding cassette (ABC) superfamily comprises a large group of ubiquitous transmembrane proteins that play a crucial role in transporting a diverse spectrum of substrates across cellular membranes. They participate in a wide array of physiological and pathological processes including nutrient uptake, antigen presentation, toxin elimination, and drug resistance in cancer and microbial cells. ABC
-
Spleen-targeted neoantigen DNA vaccine for personalized immunotherapy of hepatocellular carcinoma EMBO Mol. Med. (IF 11.1) Pub Date : 2023-08-08 Ming Wu, Zijin Luo, Zhixiong Cai, Qianqian Mao, Zhenli Li, Hao Li, Cao Zhang, Yuting Zhang, Aoxue Zhong, Liming Wu, Xiaolong Liu
Neoantigens are emerging as attractive targets to develop personalized cancer vaccines, but their immunization efficacy is severely hampered by their restricted accessibility to lymphoid tissues where immune responses are initiated. Leveraging the capability of red blood cells (RBCs) to capture and present pathogens in peripheral blood to the antigen-presenting cells (APCs) in spleen, we developed
-
Deconvoluting gene and environment interactions to develop an “epigenetic score meter” of disease EMBO Mol. Med. (IF 11.1) Pub Date : 2023-08-04 Alessio Butera, Lena Smirnova, Elisa Ferrando-May, Thomas Hartung, Thomas Brunner, Marcel Leist, Ivano Amelio
Human health is determined both by genetics (G) and environment (E). This is clearly illustrated in groups of individuals who are exposed to the same environmental factor showing differential responses. A quantitative measure of the gene–environment interactions (GxE) effects has not been developed and in some instances, a clear consensus on the concept has not even been reached; for example, whether
-
Graft conditioning with fluticasone propionate reduces graft-versus-host disease upon allogeneic hematopoietic cell transplantation in mice EMBO Mol. Med. (IF 11.1) Pub Date : 2023-08-04 Erika S Varady, L Angel Ayala, Pauline U Nguyen, Vanessa M Scarfone, Alborz Karimzadeh, Cuiwen Zhou, Xiyu Chen, Scott A Greilach, Craig M Walsh, Matthew A Inlay
Hematopoietic cell transplantation (HCT) treats many blood conditions but remains underused due to complications such as graft-versus-host disease (GvHD). In GvHD, donor immune cells attack the patient, requiring powerful immunosuppressive drugs like glucocorticoids (GCs) to prevent death. In this study, we tested the hypothesis that donor cell conditioning with the glucocorticoid fluticasone propionate
-
Metabolic switch from fatty acid oxidation to glycolysis in knock-in mouse model of Barth syndrome EMBO Mol. Med. (IF 11.1) Pub Date : 2023-08-03 Arpita Chowdhury, Angela Boshnakovska, Abhishek Aich, Aditi Methi, Ana Maria Vergel Leon, Ivan Silbern, Christian Lüchtenborg, Lukas Cyganek, Jan Prochazka, Radislav Sedlacek, Jiri Lindovsky, Dominic Wachs, Zuzana Nichtova, Dagmar Zudova, Gizela Koubkova, André Fischer, Henning Urlaub, Britta Brügger, Dörthe M Katschinski, Jan Dudek, Peter Rehling
Mitochondria are central for cellular metabolism and energy supply. Barth syndrome (BTHS) is a severe disorder, due to dysfunction of the mitochondrial cardiolipin acyl transferase tafazzin. Altered cardiolipin remodeling affects mitochondrial inner membrane organization and function of membrane proteins such as transporters and the oxidative phosphorylation (OXPHOS) system. Here, we describe a mouse
-
Viral anti-inflammatory serpin reduces immuno-coagulopathic pathology in SARS-CoV-2 mouse models of infection EMBO Mol. Med. (IF 11.1) Pub Date : 2023-08-03 Liqiang Zhang, Yize (Henry) Li, Karen Kibler, Simona Kraberger, Arvind Varsani, Julie Turk, Nora Elmadbouly, Emily Aliskevich, Laurel Spaccarelli, Bereket Estifanos, Junior Enow, Isabela Rivabem Zanetti, Nicholas Saldevar, Efrem Lim, Jessika Schlievert, Kyle Browder, Anjali Wilson, Fernando Arcos Juan, Aubrey Pinteric, Aman Garg, Henna Monder, Rohan Saju, Savanah Gisriel, Bertram Jacobs, Timothy L
SARS-CoV-2 acute respiratory distress syndrome (ARDS) induces uncontrolled lung inflammation and coagulopathy with high mortality. Anti-viral drugs and monoclonal antibodies reduce early COVID-19 severity, but treatments for late-stage immuno-thrombotic syndromes and long COVID are limited. Serine protease inhibitors (SERPINS) regulate activated proteases. The myxoma virus-derived Serp-1 protein is
-
Single-cell profiling of muscle-infiltrating T cells in idiopathic inflammatory myopathies EMBO Mol. Med. (IF 11.1) Pub Date : 2023-07-31 Alexandra Argyriou, Begum Horuluoglu, Angeles Shunashy Galindo-Feria, Juan Sebastian Diaz-Boada, Merel Sijbranda, Antonella Notarnicola, Lara Dani, Annika van Vollenhoven, Daniel Ramsköld, Inger Nennesmo, Maryam Dastmalchi, Ingrid E Lundberg, Lina-Marcela Diaz-Gallo, Karine Chemin
Idiopathic inflammatory myopathies (IIM) are rare autoimmune systemic diseases characterized by muscle weakness and the presence of muscle-infiltrating T cells. IIM represent a clinical challenge due to heterogeneity of symptoms and variability of response to immunosuppressive treatment. Here, we performed in-depth single-cell sequencing on muscle-infiltrating T cells and peripheral blood memory T
-
Analysis of SARS-CoV-2 mutations associated with resistance to therapeutic monoclonal antibodies that emerge after treatment Drug Resist. Updat. (IF 24.3) Pub Date : 2023-07-31 Daniele Focosi, Scott McConnell, David J. Sullivan, Arturo Casadevall
The mutation rate of the Omicron sublineage has led to baseline resistance against all previously authorized anti-Spike monoclonal antibodies (mAbs). Nevertheless, in case more antiviral mAbs will be authorized in the future, it is relevant to understand how frequently treatment-emergent resistance has emerged so far, under different combinations and in different patient subgroups. We report the results
-
Quantitative multiorgan proteomics of fatal COVID-19 uncovers tissue-specific effects beyond inflammation EMBO Mol. Med. (IF 11.1) Pub Date : 2023-07-31 Lisa Schweizer, Tina Schaller, Maximilian Zwiebel, Özge Karayel, Johannes Bruno Müller-Reif, Wen-Feng Zeng, Sebastian Dintner, Thierry M Nordmann, Klaus Hirschbühl, Bruno Märkl, Rainer Claus, Matthias Mann
SARS-CoV-2 may directly and indirectly damage lung tissue and other host organs, but there are few system-wide, untargeted studies of these effects on the human body. Here, we developed a parallelized mass spectrometry (MS) proteomics workflow enabling the rapid, quantitative analysis of hundreds of virus-infected FFPE tissues. The first layer of response to SARS-CoV-2 in all tissues was dominated
-
Targeting CD301+ macrophages inhibits endometrial fibrosis and improves pregnancy outcome EMBO Mol. Med. (IF 11.1) Pub Date : 2023-07-31 Haining Lv, Haixiang Sun, Limin Wang, Simin Yao, Dan Liu, Xiwen Zhang, Zhongrui Pei, Jianjun Zhou, Huiyan Wang, Jianwu Dai, Guijun Yan, Lijun Ding, Zhiyin Wang, Chenrui Cao, Guangfeng Zhao, Yali Hu
Macrophages are a key and heterogeneous cell population involved in endometrial repair and regeneration during the menstrual cycle, but their role in the development of intrauterine adhesion (IUA) and sequential endometrial fibrosis remains unclear. Here, we reported that CD301+ macrophages were significantly increased and showed their most active interaction with profibrotic cells in the endometria
-
Pathophysiological roles and applications of glycosphingolipids in the diagnosis and treatment of cancer diseases Prog. Lipid. Res. (IF 13.6) Pub Date : 2023-07-29 Xuefeng Jin, Guang-Yu Yang
Glycosphingolipids (GSLs) are major amphiphilic glycolipids present on the surface of living cell membranes. They have important biological functions, including maintaining plasma membrane stability, regulating signal transduction, and mediating cell recognition and adhesion. Specific GSLs and related enzymes are abnormally expressed in many cancer diseases and affect the malignant characteristics
-
Musculoskeletal defects associated with myosin heavy chain-embryonic loss of function are mediated by the YAP signaling pathway EMBO Mol. Med. (IF 11.1) Pub Date : 2023-07-26 Anushree Bharadwaj, Jaydeep Sharma, Jagriti Singh, Mahima Kumari, Tanushri Dargar, Bhargab Kalita, Sam J Mathew
Mutations in MYH3, the gene encoding the developmental myosin heavy chain-embryonic (MyHC-embryonic) skeletal muscle-specific contractile protein, cause several congenital contracture syndromes. Among these, recessive loss-of-function MYH3 mutations lead to spondylocarpotarsal synostosis (SCTS), characterized by vertebral fusions and scoliosis. We find that Myh3 germline knockout adult mice display
-
Platelet-derived lipids promote insulin secretion of pancreatic β cells EMBO Mol. Med. (IF 11.1) Pub Date : 2023-07-25 Till Karwen, Katarzyna Kolczynska-Matysiak, Carina Gross, Mona C Löffler, Mike Friedrich, Angel Loza-Valdes, Werner Schmitz, Magdalena Wit, Filip Dziaczkowski, Andrei Belykh, Jonathan Trujillo-Viera, Rabih El-Merahbi, Carsten Deppermann, Sameena Nawaz, Benoit Hastoy, Agnieszka Demczuk, Manuela Erk, Mariusz R Wieckowski, Patrik Rorsman, Katrin G Heinze, David Stegner, Bernhard Nieswandt, Grzegorz Sumara
Hyperreactive platelets are commonly observed in diabetic patients indicating a potential link between glucose homeostasis and platelet reactivity. This raises the possibility that platelets may play a role in the regulation of metabolism. Pancreatic β cells are the central regulators of systemic glucose homeostasis. Here, we show that factor(s) derived from β cells stimulate platelet activity and
-
ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer EMBO Mol. Med. (IF 11.1) Pub Date : 2023-07-25 Christopher W Schultz, Yang Zhang, Rajaa Elmeskini, Astrid Zimmermann, Haiqing Fu, Yasuhisa Murai, Darawalee Wangsa, Suresh Kumar, Nobuyuki Takahashi, Devon Atkinson, Liton Kumar Saha, Chien-Fei Lee, Brian Elenbaas, Parth Desai, Robin Sebastian, Ajit Kumar Sharma, Melissa Abel, Brett Schroeder, Manan Krishnamurthy, Rajesh Kumar, Nitin Roper, Mirit Aladjem, Frank T Zenke, Zoe Weaver Ohler, Yves Pommier
Small-cell lung cancer (SCLC) is the most lethal type of lung cancer. Specifically, MYC-driven non-neuroendocrine SCLC is particularly resistant to standard therapies. Lurbinectedin was recently approved for the treatment of relapsed SCLC, but combinatorial approaches are needed to increase the depth and duration of responses to lurbinectedin. Using high-throughput screens, we found inhibitors of ataxia
-
Can the new adipokine asprosin be a metabolic troublemaker for cardiovascular diseases? A state-of-the-art review Prog. Lipid. Res. (IF 13.6) Pub Date : 2023-07-19 Zhengbin Zhang, Liwen Zhu, Ziqian Wang, Ning Hua, Shunying Hu, Yundai Chen
Adipokines play a significant role in cardiometabolic diseases. Asprosin, a newly discovered adipokine, was first identified as a glucose-raising protein hormone. Asprosin also stimulates appetite and regulates glucose and lipid metabolism. Its identified receptors so far include Olfr734 and Ptprd. Clinical studies have found that asprosin may be associated with cardiometabolic diseases. Asprosin may
-
Actionable loss of SLF2 drives B-cell lymphomagenesis and impairs the DNA damage response EMBO Mol. Med. (IF 11.1) Pub Date : 2023-07-24 Le Zhang, Matthias Wirth, Upayan Patra, Jacob Stroh, Konstandina Isaakidis, Leonie Rieger, Susanne Kossatz, Maja Milanovic, Chuanbing Zang, Uta Demel, Jan Keiten-Schmitz, Kristina Wagner, Katja Steiger, Roland Rad, Florian Bassermann, Stefan Müller, Ulrich Keller, Markus Schick
The DNA damage response (DDR) acts as a barrier to malignant transformation and is often impaired during tumorigenesis. Exploiting the impaired DDR can be a promising therapeutic strategy; however, the mechanisms of inactivation and corresponding biomarkers are incompletely understood. Starting from an unbiased screening approach, we identified the SMC5-SMC6 Complex Localization Factor 2 (SLF2) as
-
NR5A2/HSD3B1 pathway promotes cellular resistance to second-generation antiandrogen darolutamide Drug Resist. Updat. (IF 24.3) Pub Date : 2023-07-17
This study investigated cellular mechanisms in steroidogenesis responsible for treatment resistance to the novel antiandrogen agent darolutamide in prostate cancer. HSD3B1 was overexpressed in darolutamide-resistant cells and induced by darolutamide treatment and AR knockdown. Inversely, HSD3B1 knockdown increased cellular sensitivity to darolutamide. Similarly, its upstream regulator NR5A2 was up-regulated
-
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα+ breast cancer EMBO Mol. Med. (IF 11.1) Pub Date : 2023-07-17 Coralie Poulard, Thuy Ha Pham, Youenn Drouet, Julien Jacquemetton, Ausra Surmielova, Loay Kassem, Benoite Mery, Christine Lasset, Jonathan Reboulet, Isabelle Treilleux, Elisabetta Marangoni, Olivier Trédan, Muriel Le Romancer
Endocrine therapies targeting estrogen signaling, such as tamoxifen, have significantly improved management of estrogen receptor alpha (ERα)-positive breast cancers. However, their efficacy is limited by intrinsic and acquired resistance to treatment, and there is currently no predictive marker of response to these anti-estrogens to guide treatment decision. Here, using two independent cohorts of breast
-
Identification of TMexCD-TOprJ-producing carbapenem-resistant Gram-negative bacteria from hospital sewage Drug Resist. Updat. (IF 24.3) Pub Date : 2023-07-13 Jie Zhu, Jingnan Lv, Zhichen Zhu, Tao Wang, Xiaofang Xie, Haifang Zhang, Liang Chen, Hong Du
Carbapenems and tigecycline are crucial antimicrobials for the treatment of gram-negative bacteria infections. Recently, a novel resistance-nodulation-division (RND) efflux pump gene cluster, tmexCD-toprJ, which confers resistance to tigecycline, has been discovered in animals and clinical isolates. It was reported that hospital sewage could act as a reservoir for gram-negative bacteria with high antimicrobial
-
LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastoma EMBO Mol. Med. (IF 11.1) Pub Date : 2023-07-12 Hamed Alborzinia, Zhiyi Chen, Umut Yildiz, Florencio Porto Freitas, Felix C E Vogel, Julianna Patricia Varga, Jasmin Batani, Christoph Bartenhagen, Werner Schmitz, Gabriele Büchel, Bernhard Michalke, Jashuo Zheng, Svenja Meierjohann, Enrico Girardi, Elisa Espinet, Andrés F Flórez, Ancely Ferreira dos Santos, Nesrine Aroua, Tasneem Cheytan, Julie Haenlin, Lisa Schlicker, Thamara N Xavier da Silva, Adriana
Ferroptosis has emerged as an attractive strategy in cancer therapy. Understanding the operational networks regulating ferroptosis may unravel vulnerabilities that could be harnessed for therapeutic benefit. Using CRISPR-activation screens in ferroptosis hypersensitive cells, we identify the selenoprotein P (SELENOP) receptor, LRP8, as a key determinant protecting MYCN-amplified neuroblastoma cells
-
Answer to Gerber et al. "Autosomal recessive pathogenic MSTO1 variants in hereditary optic atrophy". EMBO Mol. Med. (IF 11.1) Pub Date : 2023-07-11 Anikó Gál,Janine H Santos,Mária Judit Molnár,György Hajnóczky
Gal et al address the issues raised by Gerber et al and reiterate that patients in their study showed decreased Misato homolog 1 (MSTO1) mRNA and protein levels, but also confirm finding of Gerber et al that the mutation is in MSTO2p pseudogene. Whether MSTO2p variant contributes to the observed decrease in MSTO1 levels in patients remains unclear.
-
Autosomal recessive pathogenic MSTO1 variants in hereditary optic atrophy. EMBO Mol. Med. (IF 11.1) Pub Date : 2023-07-11 Sylvie Gerber,Lola Lessard,Cécile Rouzier,Samira Ait-El-Mkadem Saadi,Roxana Ameli,Stéphane Thobois,Lucie Abouaf,Françoise Bouhour,Josseline Kaplan,Audrey Putoux,Antoine Pegat,Jean-Michel Rozet
Gerber et al report 2 autosomal recessive pathogenic Misato homolog 1 (MSTO1) variants causing hereditary optic atrophy and raise concerns about a previously identified dominant variant of MSTO1 by Gal et al (2017).
-
New emerging SARS-CoV-2 variants and antiviral agents Drug Resist. Updat. (IF 24.3) Pub Date : 2023-06-26 A. Vitiello, A. Zovi, G. Rezza
Abstract not available
-
Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies Drug Resist. Updat. (IF 24.3) Pub Date : 2023-06-28 Wenhui Jia, Zhao Huang, Li Zhou, Yih-Cherng Liou, Francesco Di Virgilio, Henning Ulrich, Peter Illes, Wei Zhang, Canhua Huang, Yong Tang
Purinergic signalling, consisting of extracellular purines and purinergic receptors, modulates cell proliferation, invasion and immunological reaction during cancer progression. Here, we focus on current evidence that suggests the crucial role of purinergic signalling in mediating cancer therapeutic resistance, the major obstacle in cancer treatment. Mechanistically, purinergic signalling can modulate
-
Endocannabinoid signaling in adult hippocampal neurogenesis: A mechanistic and integrated perspective Prog. Lipid. Res. (IF 13.6) Pub Date : 2023-06-27 Sergio Oddi, Maria Teresa Fiorenza, Mauro Maccarrone
Dentate gyrus of the hippocampus continuously gives rise to new neurons, namely, adult-born granule cells, which contribute to conferring plasticity to the mature brain throughout life. Within this neurogenic region, the fate and behavior of neural stem cells (NSCs) and their progeny result from a complex balance and integration of a variety of cell-autonomous and cell-to-cell-interaction signals and
-
Targeting shared molecular etiologies to accelerate drug development for rare diseases EMBO Mol. Med. (IF 11.1) Pub Date : 2023-06-27 Galliano Zanello, Macarena Garrido-Estepa, Ana Crespo, Daniel O'Connor, Rima Nabbout, Christina Waters, Anthony Hall, Maurizio Taglialatela, Chun-Hung Chan, David A Pearce, Marc Dooms, Philip John Brooks
Rare diseases affect over 400 million people worldwide and less than 5% of rare diseases have an approved treatment. Fortunately, the number of underlying disease etiologies is far less than the number of diseases, because many rare diseases share a common molecular etiology. Moreover, many of these shared molecular etiologies are therapeutically actionable. Grouping rare disease patients for clinical
-
Inhibition of DHCR24 activates LXRα to ameliorate hepatic steatosis and inflammation EMBO Mol. Med. (IF 11.1) Pub Date : 2023-06-26 Enchen Zhou, Xiaoke Ge, Hiroyuki Nakashima, Rumei Li, Hendrik J P van der Zande, Cong Liu, Zhuang Li, Christoph Müller, Franz Bracher, Yassene Mohammed, Jan Freark de Boer, Folkert Kuipers, Bruno Guigas, Christopher K Glass, Patrick C N Rensen, Martin Giera, Yanan Wang
Liver X receptor (LXR) agonism has theoretical potential for treating NAFLD/NASH, but synthetic agonists induce hyperlipidemia in preclinical models. Desmosterol, which is converted by Δ24-dehydrocholesterol reductase (DHCR24) into cholesterol, is a potent endogenous LXR agonist with anti-inflammatory properties. We aimed to investigate the effects of DHCR24 inhibition on NAFLD/NASH development. Here